These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33940155)

  • 21. Relationship between AHSP gene expression, β/α globin mRNA ratio, and clinical severity of the β-thalassemia patients.
    Ranjbaran R; Okhovat MA; Mobarhanfard A; Aboualizadeh F; Abbasi M; Moezzi L; Golafshan HA; Behzad-Behbahani A; Bagheri M; Sharifzadeh S
    Ann Clin Lab Sci; 2014; 44(2):189-93. PubMed ID: 24795058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the transcriptional read-through rate of a lentiviral vector for β-thalassemia gene therapy.
    Wu J; Chen Y; Shen W; Zhang J; Zeng F
    J Gene Med; 2024 Jan; 26(1):e3640. PubMed ID: 37989259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells.
    Lazaris VM; Simantirakis E; Stavrou EF; Verras M; Sgourou A; Keramida MK; Vassilopoulos G; Athanassiadou A
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells.
    Papanikolaou E; Georgomanoli M; Stamateris E; Panetsos F; Karagiorga M; Tsaftaridis P; Graphakos S; Anagnou NP
    Hum Gene Ther; 2012 Jan; 23(1):15-31. PubMed ID: 21875313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of correct β
    Nualkaew T; Jearawiriyapaisarn N; Hongeng S; Fucharoen S; Kole R; Svasti S
    Sci Rep; 2019 May; 9(1):7672. PubMed ID: 31113996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preclinical approach for gene therapy of beta-thalassemia.
    Breda L; Kleinert DA; Casu C; Casula L; Cartegni L; Fibach E; Mancini I; Giardina PJ; Gambari R; Rivella S
    Ann N Y Acad Sci; 2010 Aug; 1202():134-40. PubMed ID: 20712784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
    Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
    J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of optimal expression cassette in retrovirus vector for beta-thalassemia gene therapy.
    Dong WJ; Li B; Liu DP; Zu ZX; Li J; Hao DL; Liu G; Guo ZC; Liang CC
    Mol Biotechnol; 2003 Jun; 24(2):127-40. PubMed ID: 12746554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
    Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
    Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Globin as a molecular target in the treatment of β-thalassemia.
    Mettananda S; Gibbons RJ; Higgs DR
    Blood; 2015 Jun; 125(24):3694-701. PubMed ID: 25869286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
    Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
    Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
    Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
    Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Therapy and Genome Editing.
    Boulad F; Mansilla-Soto J; Cabriolu A; Rivière I; Sadelain M
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):329-342. PubMed ID: 29458735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic therapy for beta-thalassemia: from the bench to the bedside.
    Arumugam P; Malik P
    Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
    Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
    Cavazzana-Calvo M; Payen E; Negre O; Wang G; Hehir K; Fusil F; Down J; Denaro M; Brady T; Westerman K; Cavallesco R; Gillet-Legrand B; Caccavelli L; Sgarra R; Maouche-Chrétien L; Bernaudin F; Girot R; Dorazio R; Mulder GJ; Polack A; Bank A; Soulier J; Larghero J; Kabbara N; Dalle B; Gourmel B; Socie G; Chrétien S; Cartier N; Aubourg P; Fischer A; Cornetta K; Galacteros F; Beuzard Y; Gluckman E; Bushman F; Hacein-Bey-Abina S; Leboulch P
    Nature; 2010 Sep; 467(7313):318-22. PubMed ID: 20844535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.